Monday, December 19, 2011

Neuropsychopharmacology - Table of Contents alert Volume 37 Issue 2


TABLE OF CONTENTS

Volume 37, Issue 2 (January 2012)

In this issue
Commentaries
Original Articles
Erratum

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Read a FREE issue of Neuropsychopharmacology today!

Neuropsychopharmacology – the official journal of the American College of Neuropsychopharmacology – is dedicated to publishing highly-ranked research in psychiatry, neuroscience, pharmacology and pharmacy. To learn more and to read a FREE sample issue online, visit www.neuropsychopharmacology.org.
 

Commentaries

Top

The Many Faces of MeCP2

Jacqueline F McGinty

Neuropsychopharmacology 2011 37: 313-314; 10.1038/npp.2011.246

Full Text

Association of Mu-opioid and NMDA Receptors in the Periaqueductal Gray: What Does it Mean for Pain Control?

Susan L Ingram

Neuropsychopharmacology 2011 37: 315-316; 10.1038/npp.2011.241

Full Text

Expanding Our Understanding of Neurobiological Mechanisms of Resilience by Using Animal Models

Israel Liberzon and Dayan Knox

Neuropsychopharmacology 2011 37: 317-318; 10.1038/npp.2011.259

Full Text

Gestational Methylazoxymethanol Acetate Administration Alters Proteomic and Metabolomic Markers of Hippocampal Glutamatergic Transmission

Daniel J Lodge and Anthony A Grace

Neuropsychopharmacology 2011 37: 319-320; 10.1038/npp.2011.255

Full Text

Original Articles

Top

Differential Regulation of MeCP2 Phosphorylation in the CNS by Dopamine and Serotonin

Ashley N Hutchinson, Jie V Deng, Dipendra K Aryal, William C Wetsel and Anne E West

Neuropsychopharmacology 2011 37: 321-337; advance online publication, September 28, 2011; 10.1038/npp.2011.190

Abstract | Full Text

The Mu-Opioid Receptor and the NMDA Receptor Associate in PAG Neurons: Implications in Pain Control

María Rodríguez-Muñoz, Pilar Sánchez-Blázquez, Ana Vicente-Sánchez, Esther Berrocoso and Javier Garzón

Neuropsychopharmacology 2011 37: 338-349; advance online publication, August 3, 2011; 10.1038/npp.2011.155

Abstract | Full Text

The Neuropeptide Y (NPY)-ergic System is Associated with Behavioral Resilience to Stress Exposure in an Animal Model of Post-Traumatic Stress Disorder

Hagit Cohen, Tianmin Liu, Nitsan Kozlovsky, Zeev Kaplan, Joseph Zohar and Aleksander A Mathé

Neuropsychopharmacology 2011 37: 350-363; advance online publication, October 5, 2011; 10.1038/npp.2011.230

Abstract | Full Text

The Methylazoxymethanol Acetate (MAM-E17) Rat Model: Molecular and Functional Effects in the Hippocampus

Eva Hradetzky, Thomas M Sanderson, Tsz M Tsang, John L Sherwood, Stephen M Fitzjohn, Viktor Lakics, Nadia Malik, Stephanie Schoeffmann, Michael J O'Neill, Tammy MK Cheng, Laura W Harris, Hassan Rahmoune, Paul C Guest, Emanuele Sher, Graham L Collingridge, Elaine Holmes, Mark D Tricklebank and Sabine Bahn

Neuropsychopharmacology 2011 37: 364-377; advance online publication, September 28, 2011; 10.1038/npp.2011.219

Abstract | Full Text

Activation of Nociceptin/Orphanin FQ Peptide Receptors Disrupts Visual but Not Auditory Sensorimotor Gating in BALB/cByJ Mice: Comparison to Dopamine Receptor Agonists

Aurelia Ces, David Reiss, Ondine Walter, Jürgen Wichmann, Eric P Prinssen, Brigitte L Kieffer and Abdel-Mouttalib Ouagazzal

Neuropsychopharmacology 2011 37: 378-389; advance online publication, August 31, 2011; 10.1038/npp.2011.175

Abstract | Full Text

Estradiol Modulates Effort-Based Decision Making in Female Rats

Kristina A Uban, Julia Rummel, Stan B Floresco and Liisa A M Galea

Neuropsychopharmacology 2011 37: 390-401; advance online publication, August 31, 2011; 10.1038/npp.2011.176

Abstract | Full Text

The Alcohol Clinical Trials Initiative (ACTIVE): Purpose and Goals for Assessing Important and Salient Issues for Medications Development in Alcohol Use Disorders

Raymond F Anton, Raye Z Litten, Daniel E Falk, Joseph M Palumbo, Raymond T Bartus, Rebecca L Robinson, Henry R Kranzler, Thomas R Kosten, Roger E Meyer, Charles P O'Brien, Karl Mann and Didier Meulien the ACTIVE Workgroup

Neuropsychopharmacology 2011 37: 402-411; advance online publication, September 7, 2011; 10.1038/npp.2011.182

Abstract | Full Text

Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm

Andrés Uribe-Mariño, Audrey Francisco, Maria Angélica Castiblanco-Urbina, André Twardowschy, Carlos José Salgado-Rohner, José Alexandre S Crippa, Jaime Eduardo Cecílio Hallak, Antônio Waldo Zuardi and Norberto Cysne Coimbra

Neuropsychopharmacology 2011 37: 412-421; advance online publication, September 14, 2011; 10.1038/npp.2011.188

Abstract | Full Text

GABAA Receptor Blockade Enhances Memory Consolidation by Increasing Hippocampal BDNF Levels

Dong Hyun Kim, Jong Min Kim, Se Jin Park, Mudan Cai, Xiaotong Liu, Seungheon Lee, Chan Young Shin and Jong Hoon Ryu

Neuropsychopharmacology 2011 37: 422-433; advance online publication, September 7, 2011; 10.1038/npp.2011.189

Abstract | Full Text

7,8-Dihydroxyflavone, a Small-Molecule TrkB Agonist, Reverses Memory Deficits and BACE1 Elevation in a Mouse Model of Alzheimer's Disease

Latha Devi and Masuo Ohno

Neuropsychopharmacology 2011 37: 434-444; advance online publication, September 7, 2011; 10.1038/npp.2011.191

Abstract | Full Text

Pharmacogenetics of Naltrexone in Asian Americans: A Randomized Placebo-Controlled Laboratory Study

Lara A Ray, Spencer Bujarski, Pauline F Chin and Karen Miotto

Neuropsychopharmacology 2011 37: 445-455; advance online publication, September 7, 2011; 10.1038/npp.2011.192

Abstract | Full Text

Cannabinoids Prevent the Development of Behavioral and Endocrine Alterations in a Rat Model of Intense Stress

Eti Ganon-Elazar and Irit Akirav

Neuropsychopharmacology 2011 37: 456-466; advance online publication, September 14, 2011; 10.1038/npp.2011.204

Abstract | Full Text

Subjective and Neural Responses to Intravenous Alcohol in Young Adults with Light and Heavy Drinking Patterns

Jodi M Gilman, Vijay A Ramchandani, Tess Crouss and Daniel W Hommer

Neuropsychopharmacology 2011 37: 467-477; advance online publication, September 28, 2011; 10.1038/npp.2011.206

Abstract | Full Text

Opposing Roles for Cannabinoid Receptor Type-1 (CB1) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats

Plínio C Casarotto, Ana Luisa B Terzian, Daniele C Aguiar, Hélio Zangrossi, Francisco S Guimarães, Carsten T Wotjak and Fabrício A Moreira

Neuropsychopharmacology 2011 37: 478-486; advance online publication, September 21, 2011; 10.1038/npp.2011.207

Abstract | Full Text

Distinct Contributions of Dopamine in the Dorsolateral Striatum and Nucleus Accumbens Shell to the Reinforcing Properties of Cocaine

Maartje M J Veeneman, Mark H Broekhoven, Ruth Damsteegt and Louk J M J Vanderschuren

Neuropsychopharmacology 2011 37: 487-498; advance online publication, September 14, 2011; 10.1038/npp.2011.209

Abstract | Full Text

Investigation of Anatomical Thalamo-Cortical Connectivity and fMRI Activation in Schizophrenia

Stefano Marenco, Jason L Stein, Antonina A Savostyanova, Fabio Sambataro, Hao-Yang Tan, Aaron L Goldman, Beth A Verchinski, Alan S Barnett, Dwight Dickinson, José A Apud, Joseph H Callicott, Andreas Meyer-Lindenberg and Daniel R Weinberger

Neuropsychopharmacology 2011 37: 499-507; advance online publication, September 28, 2011; 10.1038/npp.2011.215

Abstract | Full Text

Dopamine Receptor Blockade Attenuates the General Incentive Motivational Effects of Noncontingently Delivered Rewards and Reward-Paired Cues Without Affecting Their Ability to Bias Action Selection

Sean B Ostlund and Nigel T Maidment

Neuropsychopharmacology 2011 37: 508-519; advance online publication, September 14, 2011; 10.1038/npp.2011.217

Abstract | Full Text

Corticotropin-Releasing Factor in the Norepinephrine Nucleus, Locus Coeruleus, Facilitates Behavioral Flexibility

Kevin Snyder, Wei-Wen Wang, Rebecca Han, Kile McFadden and Rita J Valentino

Neuropsychopharmacology 2011 37: 520-530; advance online publication, October 12, 2011; 10.1038/npp.2011.218

Abstract | Full Text

Growth Arrest and DNA-Damage-Inducible, Beta (GADD45b)-Mediated DNA Demethylation in Major Psychosis

David P Gavin, Rajiv P Sharma, Kayla A Chase, Francesco Matrisciano, Erbo Dong and Alessandro Guidotti

Neuropsychopharmacology 2011 37: 531-542; advance online publication, November 2, 2011; 10.1038/npp.2011.221

Abstract | Full Text

Reversal of Dopamine Inhibition of Dopaminergic Neurons of the Ventral Tegmental Area is Mediated by Protein Kinase C

Sudarat Nimitvilai, Devinder S Arora and Mark S Brodie

Neuropsychopharmacology 2011 37: 543-556; advance online publication, October 5, 2011; 10.1038/npp.2011.222

Abstract | Full Text

Genome-Wide Association Study of Alcohol Dependence Implicates KIAA0040 on Chromosome 1q

Lingjun Zuo, Joel Gelernter, Clarence K Zhang, Hongyu Zhao, Lingeng Lu, Henry R Kranzler, Robert T Malison, Chiang-Shan R Li, Fei Wang, Xiang-Yang Zhang, Hong-Wen Deng, John H Krystal, Fengyu Zhang and Xingguang Luo

Neuropsychopharmacology 2011 37: 557-566; advance online publication, September 28, 2011; 10.1038/npp.2011.229

Abstract | Full Text

Early Life Stress Inhibits Expression of a Novel Innate Immune Pathway in the Developing Hippocampus

Lan Wei, Arthur Simen, Shrikant Mane and Arie Kaffman

Neuropsychopharmacology 2011 37: 567-580; advance online publication, October 12, 2011; 10.1038/npp.2011.239

Abstract | Full Text

Erratum

Top

Genome-Wide Association Study of Alcohol Dependence Implicates KIAA0040 on Chromosome 1q

Lingjun Zuo, Joel Gelernter, Clarence K Zhang, Hongyu Zhao, Lingeng Lu, Henry R Kranzler, Robert T Malison, Chiang-Shan R Li, Fei Wang, Xiang-Yang Zhang, Hong-Wen Deng, John H Krystal, Fengyu Zhang and Xingguang Luo

Neuropsychopharmacology 2012 37: 581-582; 10.1038/npp.2011.271

Full Text

Advertisement
Neuropsychopharmacology Reviews
Highlighting Neurotherapeutics in 2012

Published each January as a special issue of Neuropsychopharmacology, the 2012 edition highlights Neurotherapeutics, with a thorough look at hot topics in this area and in-depth review articles.

Visit www.neuropsychopharmacology.org and gain access to these articles before they are published in print.
 

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: